227
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Targeted Covalent Inhibitors for Novel Therapeutics

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 1739-1741 | Received 17 Aug 2023, Accepted 22 Aug 2023, Published online: 04 Oct 2023
 

Author contributions

JY Zhang, WS Gao and YX Wang wrote the draft manuscript. B Yu and JB Chang revised the draft. B Yu, on behalf of all authors, submitted this manuscript. All authors have given approval to submission of the manuscript.

Financial disclosure

This work was supported by Natural Science Foundation of China (nos. 81973177 and 22277110), Natural Science Foundation of Henan Province (no. 222300420069) and Program for Science & Technology Innovation Talents in Universities of Henan Province (no. 21HASTIT045). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.